Stephen W. Webster
2017
In 2017, Stephen W. Webster earned a total compensation of $2M as Chief Financial Officer at Spark Therapeutics, a 3% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $219,535 |
|---|---|
| Salary | $414,423 |
| Stock Awards | $1,370,390 |
| Other | $38,942 |
| Total | $2,043,290 |
Webster received $1.4M in stock awards, accounting for 67% of the total pay in 2017.
Webster also received $219.5K in non-equity incentive plan, $414.4K in salary and $38.9K in other compensation.
Rankings
In 2017, Stephen W. Webster's compensation ranked 5,398th out of 14,666 executives tracked by ExecPay. In other words, Webster earned more than 63.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,398 out of 14,666 | 63rd |
Division Manufacturing | 1,937 out of 5,768 | 66th |
Major group Chemicals And Allied Products | 579 out of 2,074 | 72nd |
Industry group Drugs | 446 out of 1,730 | 74th |
Industry Biological Products, Except Diagnostic Substances | 81 out of 316 | 74th |
Source: SEC filing on April 20, 2018.
Webster's colleagues
We found five more compensation records of executives who worked with Stephen W. Webster at Spark Therapeutics in 2017.
2017
Jeffrey Marrazzo
Spark Therapeutics
Chief Executive Officer
2017
Katherine High
Spark Therapeutics
President and Head of Research and Development
2017
Daniel Faga
Spark Therapeutics
Chief Business Officer
2017
Joseph Barge
Spark Therapeutics
Chief Legal Officer
2017
John Furey
Spark Therapeutics